M K Freynhofer

Summary

Affiliation: Medical University of Vienna
Country: Austria

Publications

  1. doi request reprint Prognostic value of plasma von Willebrand factor and its cleaving protease ADAMTS13 in patients with atrial fibrillation
    Matthias K Freynhofer
    3rd Medical Department, Cardiology and Emergency Medicine, Wilhelminenhospital, Vienna, Austria
    Int J Cardiol 168:317-25. 2013
  2. doi request reprint Endogenous t-PA-antigen is an independent predictor of adverse cardiovascular events and all-cause death in patients with atrial fibrillation
    M K Freynhofer
    3rd Medical Department, Cardiology and Emergency Medicine, Wilhelminen Hospital, Vienna, Austria
    J Thromb Haemost 11:1069-77. 2013
  3. doi request reprint Biomarkers in acute coronary artery disease
    Matthias K Freynhofer
    3rd Department of Medicine, Cardiology and Emergency Medicine, Wilhelminen Hospital, 1160 Vienna, Austria
    Wien Med Wochenschr 162:489-98. 2012
  4. ncbi request reprint The role of platelets in athero-thrombotic events
    Matthias K Freynhofer
    3rd Department of Medicine, Cardiology and Emergency Medicine, Wilhelminen Hospital, A 1160, Vienna, Austria
    Curr Pharm Des 18:5197-214. 2012
  5. doi request reprint Vasodilator-stimulated phosphoprotein-phosphorylation assay in patients on clopidogrel: does standardisation matter?
    Matthias K Freynhofer
    3rd Medical Department, Cardiology and Emergency Medicine, Wilhelminenhospital, Vienna, Austria
    Thromb Haemost 107:538-44. 2012
  6. doi request reprint Levels of von Willebrand factor and ADAMTS13 determine clinical outcome after cardioversion for atrial fibrillation
    Matthias K Freynhofer
    3rd Department of Medicine, Cardiology and Emergency Medicine, Wilhelminen Hospital, Vienna, Austria
    Thromb Haemost 105:435-43. 2011
  7. doi request reprint Multiple electrode aggregometry and vasodilator stimulated phosphoprotein-phosphorylation assay in clinical routine for prediction of postprocedural major adverse cardiovascular events
    Matthias K Freynhofer
    3rd Department of Medicine, Cardiology and Emergency Medicine, Wilhelminen Hospital, A 1160, Vienna, Austria
    Thromb Haemost 106:230-9. 2011
  8. doi request reprint Antithrombotic therapy in patients with acute coronary syndrome and diabetes mellitus
    S Farhan
    3rd Department of Medicine, Cardiology and Emergency Medicine, Wilhelminenhospital, Vienna, Montleartstr 37, 1160, Vienna, Austria
    Herz 37:264-72. 2012

Detail Information

Publications8

  1. doi request reprint Prognostic value of plasma von Willebrand factor and its cleaving protease ADAMTS13 in patients with atrial fibrillation
    Matthias K Freynhofer
    3rd Medical Department, Cardiology and Emergency Medicine, Wilhelminenhospital, Vienna, Austria
    Int J Cardiol 168:317-25. 2013
    ..We therefore investigated whether a high ratio of vWF/ADAMTS13, independently of clinical risk scores, predicts major adverse cardiovascular events (MACE) in patients with AF...
  2. doi request reprint Endogenous t-PA-antigen is an independent predictor of adverse cardiovascular events and all-cause death in patients with atrial fibrillation
    M K Freynhofer
    3rd Medical Department, Cardiology and Emergency Medicine, Wilhelminen Hospital, Vienna, Austria
    J Thromb Haemost 11:1069-77. 2013
    ....
  3. doi request reprint Biomarkers in acute coronary artery disease
    Matthias K Freynhofer
    3rd Department of Medicine, Cardiology and Emergency Medicine, Wilhelminen Hospital, 1160 Vienna, Austria
    Wien Med Wochenschr 162:489-98. 2012
    ..Finally, platelets are an old, yet rediscovered biomarker for ischemic cardiovascular outcomes that might be used to estimate the individual bleeding or thrombotic risk and to tailor antiplatelet therapy...
  4. ncbi request reprint The role of platelets in athero-thrombotic events
    Matthias K Freynhofer
    3rd Department of Medicine, Cardiology and Emergency Medicine, Wilhelminen Hospital, A 1160, Vienna, Austria
    Curr Pharm Des 18:5197-214. 2012
    ....
  5. doi request reprint Vasodilator-stimulated phosphoprotein-phosphorylation assay in patients on clopidogrel: does standardisation matter?
    Matthias K Freynhofer
    3rd Medical Department, Cardiology and Emergency Medicine, Wilhelminenhospital, Vienna, Austria
    Thromb Haemost 107:538-44. 2012
    ..Tolerably stable results were obtained for the PRI from the median FI...
  6. doi request reprint Levels of von Willebrand factor and ADAMTS13 determine clinical outcome after cardioversion for atrial fibrillation
    Matthias K Freynhofer
    3rd Department of Medicine, Cardiology and Emergency Medicine, Wilhelminen Hospital, Vienna, Austria
    Thromb Haemost 105:435-43. 2011
    ..Since ADAMTS13 plasma concentration and the vWF/ADAMTS13-ratio are independently associated with rhythm stability, these indexes might be used for prediction of recurrence of AF...
  7. doi request reprint Multiple electrode aggregometry and vasodilator stimulated phosphoprotein-phosphorylation assay in clinical routine for prediction of postprocedural major adverse cardiovascular events
    Matthias K Freynhofer
    3rd Department of Medicine, Cardiology and Emergency Medicine, Wilhelminen Hospital, A 1160, Vienna, Austria
    Thromb Haemost 106:230-9. 2011
    ..With regard to differing cut-offs, exact standardisation of the VASP-P assay is mandatory. The use of GP-IIb/IIIa-blockers prevents MEA testing and limits its usability in unselected patients...
  8. doi request reprint Antithrombotic therapy in patients with acute coronary syndrome and diabetes mellitus
    S Farhan
    3rd Department of Medicine, Cardiology and Emergency Medicine, Wilhelminenhospital, Vienna, Montleartstr 37, 1160, Vienna, Austria
    Herz 37:264-72. 2012
    ..This review article aims to shed light on and simplify antiplatelet and antithrombotic therapy in ACS patients with DM-2 in order to ease the clinician's decision-making...